The ACR and the American College of Radiology Imaging Network (ACRIN®) have a proven history in developing trials that standardize the use of imaging technologies, image transmission and archive, and quantification of image data to reduce variability associated with these activities, reduce the size and cost of trials, and produce more reliable results.

The ACR's clinical research programs are among the largest recipients of federal medical research grants and have an established reputation for handling large-scale clinical trials involving up to 50,000 patients and some 50 million images at a time. ACR Image Metrix will leverage the same infrastructure and expertise, but will provide support to pharmaceutical companies, biotechnology firms, and medical device manufacturers seeking Food and Drug Administration approval to bring new drugs, therapies, and medical devices to market.


Revenue from the various research projects carried out by ACR Image Metrix will be used to help fund future ACRIN, Radiation Therapy Oncology Group (RTOG®), and Quality Research in Radiation Oncology (Q-RRO™) studies.

To learn more about ACR Image Metrix please visit www.acr-imagemetrix.net or call (888) 817-0817.

Back to HCB News

More Voices